M&A Deal Summary

Nevro Acquires Vyrsa

On November 30, 2023, Nevro acquired medical products company Vyrsa for 75M USD

Acquisition Highlights
  • This is Nevro’s 1st transaction in the Medical Products sector.
  • This is Nevro’s largest (disclosed) transaction.
  • This is Nevro’s 1st transaction in the United States.
  • This is Nevro’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2023-11-30
Target Vyrsa
Sector Medical Products
Buyer(s) Nevro
Deal Type Add-on Acquisition
Deal Value 75M USD

Target

Vyrsa

King of Prussia, Pennsylvania, United States
Vyrsa is a privately held medical technology company focused on a minimally invasive treatment option for chronic sacroiliac joint ("SI Joint") pain patients. Vyrsa was formed in 2021 and is based in King of Prussia, Pennsylvania.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Nevro

Redwood City, California, United States
Category Company
Founded 2006
Sector Medical Products
Employees1,215
Revenue 425M USD (2023)
DESCRIPTION

Nevro is a medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro was founded in 2006 and is based in Redwood City, California.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Pennsylvania) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal